Global Gastrointestinal Drugs Supply, Demand and Key Producers, 2024-2030

Global Gastrointestinal Drugs Supply, Demand and Key Producers, 2024-2030

Page: 138

Published Date: 01 Apr 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Gastrointestinal Drugs market size is expected to reach $ 56930 million by 2030, rising at a market growth of 4.4% CAGR during the forecast period (2024-2030).

The key players of Gastrointestinal Drugs include Takeda, AstraZeneca and Bayer, etc. The top three players hold a share over 9%. Asia-Pacific is the largest market, has a share about 25%. In terms of product type, Prescription is the largest segment, occupied for a share of about 64%, and in terms of application, Inflammatory Bowel Disease has a share about 44 percent.

Gastrointestinal (GI) disorder is a functional disorder or disease which occurs when the main abnormality is the way the body works. In the doctor’s office, no structural or biochemical cause is seen. Gastrointestinal problems occur when nerves or muscles in any portion of the digestive tract do not function in a coordinated fashion, or when the sensitivity of the nerves of the intestines or the way in which the brain controls some of these functions is impaired. In this report, we study the drugs for gastrointestinal.

This report studies the global Gastrointestinal Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Gastrointestinal Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gastrointestinal Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Gastrointestinal Drugs total production and demand, 2019-2030, (M Units)
Global Gastrointestinal Drugs total production value, 2019-2030, (USD Million)
Global Gastrointestinal Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (M Units)
Global Gastrointestinal Drugs consumption by region & country, CAGR, 2019-2030 & (M Units)
U.S. VS China: Gastrointestinal Drugs domestic production, consumption, key domestic manufacturers and share
Global Gastrointestinal Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (M Units)
Global Gastrointestinal Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (M Units)
Global Gastrointestinal Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (M Units).

This reports profiles key players in the global Gastrointestinal Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, AstraZeneca, Bayer, Pfizer, Sun Pharma, Teva, Zeria, Perrigo and Eisai Co., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gastrointestinal Drugs market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Gastrointestinal Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Gastrointestinal Drugs Market, Segmentation by Type
Prescription
OTC

Global Gastrointestinal Drugs Market, Segmentation by Application
Inflammatory Bowel Disease
IBS Disease
Peptic Ulcer
GERD
Other

Companies Profiled:
Takeda
AstraZeneca
Bayer
Pfizer
Sun Pharma
Teva
Zeria
Perrigo
Eisai Co.
Abbvie
Jiangzhong
AOSAIKANG Pharma
Luoxin Pharma
LIVZON
Eastchina Pharma
Bausch Health

Key Questions Answered
1. How big is the global Gastrointestinal Drugs market?
2. What is the demand of the global Gastrointestinal Drugs market?
3. What is the year over year growth of the global Gastrointestinal Drugs market?
4. What is the production and production value of the global Gastrointestinal Drugs market?
5. Who are the key producers in the global Gastrointestinal Drugs market?
btl

Table of Contents

1 Supply Summary
1.1 Gastrointestinal Drugs Introduction
1.2 World Gastrointestinal Drugs Supply & Forecast
1.2.1 World Gastrointestinal Drugs Production Value (2019 & 2023 & 2030)
1.2.2 World Gastrointestinal Drugs Production (2019-2030)
1.2.3 World Gastrointestinal Drugs Pricing Trends (2019-2030)
1.3 World Gastrointestinal Drugs Production by Region (Based on Production Site)
1.3.1 World Gastrointestinal Drugs Production Value by Region (2019-2030)
1.3.2 World Gastrointestinal Drugs Production by Region (2019-2030)
1.3.3 World Gastrointestinal Drugs Average Price by Region (2019-2030)
1.3.4 North America Gastrointestinal Drugs Production (2019-2030)
1.3.5 Europe Gastrointestinal Drugs Production (2019-2030)
1.3.6 China Gastrointestinal Drugs Production (2019-2030)
1.3.7 Japan Gastrointestinal Drugs Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gastrointestinal Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gastrointestinal Drugs Major Market Trends

2 Demand Summary
2.1 World Gastrointestinal Drugs Demand (2019-2030)
2.2 World Gastrointestinal Drugs Consumption by Region
2.2.1 World Gastrointestinal Drugs Consumption by Region (2019-2024)
2.2.2 World Gastrointestinal Drugs Consumption Forecast by Region (2025-2030)
2.3 United States Gastrointestinal Drugs Consumption (2019-2030)
2.4 China Gastrointestinal Drugs Consumption (2019-2030)
2.5 Europe Gastrointestinal Drugs Consumption (2019-2030)
2.6 Japan Gastrointestinal Drugs Consumption (2019-2030)
2.7 South Korea Gastrointestinal Drugs Consumption (2019-2030)
2.8 ASEAN Gastrointestinal Drugs Consumption (2019-2030)
2.9 India Gastrointestinal Drugs Consumption (2019-2030)

3 World Gastrointestinal Drugs Manufacturers Competitive Analysis
3.1 World Gastrointestinal Drugs Production Value by Manufacturer (2019-2024)
3.2 World Gastrointestinal Drugs Production by Manufacturer (2019-2024)
3.3 World Gastrointestinal Drugs Average Price by Manufacturer (2019-2024)
3.4 Gastrointestinal Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Gastrointestinal Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Gastrointestinal Drugs in 2023
3.5.3 Global Concentration Ratios (CR8) for Gastrointestinal Drugs in 2023
3.6 Gastrointestinal Drugs Market: Overall Company Footprint Analysis
3.6.1 Gastrointestinal Drugs Market: Region Footprint
3.6.2 Gastrointestinal Drugs Market: Company Product Type Footprint
3.6.3 Gastrointestinal Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Gastrointestinal Drugs Production Value Comparison
4.1.1 United States VS China: Gastrointestinal Drugs Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Gastrointestinal Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Gastrointestinal Drugs Production Comparison
4.2.1 United States VS China: Gastrointestinal Drugs Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Gastrointestinal Drugs Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Gastrointestinal Drugs Consumption Comparison
4.3.1 United States VS China: Gastrointestinal Drugs Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Gastrointestinal Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Gastrointestinal Drugs Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Gastrointestinal Drugs Production Value (2019-2024)
4.4.3 United States Based Manufacturers Gastrointestinal Drugs Production (2019-2024)
4.5 China Based Gastrointestinal Drugs Manufacturers and Market Share
4.5.1 China Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Gastrointestinal Drugs Production Value (2019-2024)
4.5.3 China Based Manufacturers Gastrointestinal Drugs Production (2019-2024)
4.6 Rest of World Based Gastrointestinal Drugs Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Gastrointestinal Drugs Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Gastrointestinal Drugs Production (2019-2024)

5 Market Analysis by Type
5.1 World Gastrointestinal Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Prescription
5.2.2 OTC
5.3 Market Segment by Type
5.3.1 World Gastrointestinal Drugs Production by Type (2019-2030)
5.3.2 World Gastrointestinal Drugs Production Value by Type (2019-2030)
5.3.3 World Gastrointestinal Drugs Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Gastrointestinal Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Inflammatory Bowel Disease
6.2.2 IBS Disease
6.2.3 Peptic Ulcer
6.2.4 GERD
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Gastrointestinal Drugs Production by Application (2019-2030)
6.3.2 World Gastrointestinal Drugs Production Value by Application (2019-2030)
6.3.3 World Gastrointestinal Drugs Average Price by Application (2019-2030)

7 Company Profiles
7.1 Takeda
7.1.1 Takeda Details
7.1.2 Takeda Major Business
7.1.3 Takeda Gastrointestinal Drugs Product and Services
7.1.4 Takeda Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Takeda Recent Developments/Updates
7.1.6 Takeda Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Gastrointestinal Drugs Product and Services
7.2.4 AstraZeneca Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Bayer
7.3.1 Bayer Details
7.3.2 Bayer Major Business
7.3.3 Bayer Gastrointestinal Drugs Product and Services
7.3.4 Bayer Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Bayer Recent Developments/Updates
7.3.6 Bayer Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Gastrointestinal Drugs Product and Services
7.4.4 Pfizer Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Sun Pharma
7.5.1 Sun Pharma Details
7.5.2 Sun Pharma Major Business
7.5.3 Sun Pharma Gastrointestinal Drugs Product and Services
7.5.4 Sun Pharma Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Sun Pharma Recent Developments/Updates
7.5.6 Sun Pharma Competitive Strengths & Weaknesses
7.6 Teva
7.6.1 Teva Details
7.6.2 Teva Major Business
7.6.3 Teva Gastrointestinal Drugs Product and Services
7.6.4 Teva Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Teva Recent Developments/Updates
7.6.6 Teva Competitive Strengths & Weaknesses
7.7 Zeria
7.7.1 Zeria Details
7.7.2 Zeria Major Business
7.7.3 Zeria Gastrointestinal Drugs Product and Services
7.7.4 Zeria Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Zeria Recent Developments/Updates
7.7.6 Zeria Competitive Strengths & Weaknesses
7.8 Perrigo
7.8.1 Perrigo Details
7.8.2 Perrigo Major Business
7.8.3 Perrigo Gastrointestinal Drugs Product and Services
7.8.4 Perrigo Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Perrigo Recent Developments/Updates
7.8.6 Perrigo Competitive Strengths & Weaknesses
7.9 Eisai Co.
7.9.1 Eisai Co. Details
7.9.2 Eisai Co. Major Business
7.9.3 Eisai Co. Gastrointestinal Drugs Product and Services
7.9.4 Eisai Co. Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Eisai Co. Recent Developments/Updates
7.9.6 Eisai Co. Competitive Strengths & Weaknesses
7.10 Abbvie
7.10.1 Abbvie Details
7.10.2 Abbvie Major Business
7.10.3 Abbvie Gastrointestinal Drugs Product and Services
7.10.4 Abbvie Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Abbvie Recent Developments/Updates
7.10.6 Abbvie Competitive Strengths & Weaknesses
7.11 Jiangzhong
7.11.1 Jiangzhong Details
7.11.2 Jiangzhong Major Business
7.11.3 Jiangzhong Gastrointestinal Drugs Product and Services
7.11.4 Jiangzhong Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Jiangzhong Recent Developments/Updates
7.11.6 Jiangzhong Competitive Strengths & Weaknesses
7.12 AOSAIKANG Pharma
7.12.1 AOSAIKANG Pharma Details
7.12.2 AOSAIKANG Pharma Major Business
7.12.3 AOSAIKANG Pharma Gastrointestinal Drugs Product and Services
7.12.4 AOSAIKANG Pharma Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 AOSAIKANG Pharma Recent Developments/Updates
7.12.6 AOSAIKANG Pharma Competitive Strengths & Weaknesses
7.13 Luoxin Pharma
7.13.1 Luoxin Pharma Details
7.13.2 Luoxin Pharma Major Business
7.13.3 Luoxin Pharma Gastrointestinal Drugs Product and Services
7.13.4 Luoxin Pharma Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Luoxin Pharma Recent Developments/Updates
7.13.6 Luoxin Pharma Competitive Strengths & Weaknesses
7.14 LIVZON
7.14.1 LIVZON Details
7.14.2 LIVZON Major Business
7.14.3 LIVZON Gastrointestinal Drugs Product and Services
7.14.4 LIVZON Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 LIVZON Recent Developments/Updates
7.14.6 LIVZON Competitive Strengths & Weaknesses
7.15 Eastchina Pharma
7.15.1 Eastchina Pharma Details
7.15.2 Eastchina Pharma Major Business
7.15.3 Eastchina Pharma Gastrointestinal Drugs Product and Services
7.15.4 Eastchina Pharma Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Eastchina Pharma Recent Developments/Updates
7.15.6 Eastchina Pharma Competitive Strengths & Weaknesses
7.16 Bausch Health
7.16.1 Bausch Health Details
7.16.2 Bausch Health Major Business
7.16.3 Bausch Health Gastrointestinal Drugs Product and Services
7.16.4 Bausch Health Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Bausch Health Recent Developments/Updates
7.16.6 Bausch Health Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Gastrointestinal Drugs Industry Chain
8.2 Gastrointestinal Drugs Upstream Analysis
8.2.1 Gastrointestinal Drugs Core Raw Materials
8.2.2 Main Manufacturers of Gastrointestinal Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Gastrointestinal Drugs Production Mode
8.6 Gastrointestinal Drugs Procurement Model
8.7 Gastrointestinal Drugs Industry Sales Model and Sales Channels
8.7.1 Gastrointestinal Drugs Sales Model
8.7.2 Gastrointestinal Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Gastrointestinal Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Gastrointestinal Drugs Production Value by Region (2019-2024) & (USD Million)
Table 3. World Gastrointestinal Drugs Production Value by Region (2025-2030) & (USD Million)
Table 4. World Gastrointestinal Drugs Production Value Market Share by Region (2019-2024)
Table 5. World Gastrointestinal Drugs Production Value Market Share by Region (2025-2030)
Table 6. World Gastrointestinal Drugs Production by Region (2019-2024) & (M Units)
Table 7. World Gastrointestinal Drugs Production by Region (2025-2030) & (M Units)
Table 8. World Gastrointestinal Drugs Production Market Share by Region (2019-2024)
Table 9. World Gastrointestinal Drugs Production Market Share by Region (2025-2030)
Table 10. World Gastrointestinal Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Gastrointestinal Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Gastrointestinal Drugs Major Market Trends
Table 13. World Gastrointestinal Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (M Units)
Table 14. World Gastrointestinal Drugs Consumption by Region (2019-2024) & (M Units)
Table 15. World Gastrointestinal Drugs Consumption Forecast by Region (2025-2030) & (M Units)
Table 16. World Gastrointestinal Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Gastrointestinal Drugs Producers in 2023
Table 18. World Gastrointestinal Drugs Production by Manufacturer (2019-2024) & (M Units)
Table 19. Production Market Share of Key Gastrointestinal Drugs Producers in 2023
Table 20. World Gastrointestinal Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Gastrointestinal Drugs Company Evaluation Quadrant
Table 22. World Gastrointestinal Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Gastrointestinal Drugs Production Site of Key Manufacturer
Table 24. Gastrointestinal Drugs Market: Company Product Type Footprint
Table 25. Gastrointestinal Drugs Market: Company Product Application Footprint
Table 26. Gastrointestinal Drugs Competitive Factors
Table 27. Gastrointestinal Drugs New Entrant and Capacity Expansion Plans
Table 28. Gastrointestinal Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Gastrointestinal Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Gastrointestinal Drugs Production Comparison, (2019 & 2023 & 2030) & (M Units)
Table 31. United States VS China Gastrointestinal Drugs Consumption Comparison, (2019 & 2023 & 2030) & (M Units)
Table 32. United States Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Gastrointestinal Drugs Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Gastrointestinal Drugs Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Gastrointestinal Drugs Production (2019-2024) & (M Units)
Table 36. United States Based Manufacturers Gastrointestinal Drugs Production Market Share (2019-2024)
Table 37. China Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Gastrointestinal Drugs Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Gastrointestinal Drugs Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Gastrointestinal Drugs Production (2019-2024) & (M Units)
Table 41. China Based Manufacturers Gastrointestinal Drugs Production Market Share (2019-2024)
Table 42. Rest of World Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Gastrointestinal Drugs Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Gastrointestinal Drugs Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Gastrointestinal Drugs Production (2019-2024) & (M Units)
Table 46. Rest of World Based Manufacturers Gastrointestinal Drugs Production Market Share (2019-2024)
Table 47. World Gastrointestinal Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Gastrointestinal Drugs Production by Type (2019-2024) & (M Units)
Table 49. World Gastrointestinal Drugs Production by Type (2025-2030) & (M Units)
Table 50. World Gastrointestinal Drugs Production Value by Type (2019-2024) & (USD Million)
Table 51. World Gastrointestinal Drugs Production Value by Type (2025-2030) & (USD Million)
Table 52. World Gastrointestinal Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Gastrointestinal Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Gastrointestinal Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Gastrointestinal Drugs Production by Application (2019-2024) & (M Units)
Table 56. World Gastrointestinal Drugs Production by Application (2025-2030) & (M Units)
Table 57. World Gastrointestinal Drugs Production Value by Application (2019-2024) & (USD Million)
Table 58. World Gastrointestinal Drugs Production Value by Application (2025-2030) & (USD Million)
Table 59. World Gastrointestinal Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Gastrointestinal Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Takeda Basic Information, Manufacturing Base and Competitors
Table 62. Takeda Major Business
Table 63. Takeda Gastrointestinal Drugs Product and Services
Table 64. Takeda Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Takeda Recent Developments/Updates
Table 66. Takeda Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Gastrointestinal Drugs Product and Services
Table 70. AstraZeneca Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Bayer Basic Information, Manufacturing Base and Competitors
Table 74. Bayer Major Business
Table 75. Bayer Gastrointestinal Drugs Product and Services
Table 76. Bayer Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Bayer Recent Developments/Updates
Table 78. Bayer Competitive Strengths & Weaknesses
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer Gastrointestinal Drugs Product and Services
Table 82. Pfizer Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Pfizer Recent Developments/Updates
Table 84. Pfizer Competitive Strengths & Weaknesses
Table 85. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Sun Pharma Major Business
Table 87. Sun Pharma Gastrointestinal Drugs Product and Services
Table 88. Sun Pharma Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Sun Pharma Recent Developments/Updates
Table 90. Sun Pharma Competitive Strengths & Weaknesses
Table 91. Teva Basic Information, Manufacturing Base and Competitors
Table 92. Teva Major Business
Table 93. Teva Gastrointestinal Drugs Product and Services
Table 94. Teva Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Teva Recent Developments/Updates
Table 96. Teva Competitive Strengths & Weaknesses
Table 97. Zeria Basic Information, Manufacturing Base and Competitors
Table 98. Zeria Major Business
Table 99. Zeria Gastrointestinal Drugs Product and Services
Table 100. Zeria Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Zeria Recent Developments/Updates
Table 102. Zeria Competitive Strengths & Weaknesses
Table 103. Perrigo Basic Information, Manufacturing Base and Competitors
Table 104. Perrigo Major Business
Table 105. Perrigo Gastrointestinal Drugs Product and Services
Table 106. Perrigo Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Perrigo Recent Developments/Updates
Table 108. Perrigo Competitive Strengths & Weaknesses
Table 109. Eisai Co. Basic Information, Manufacturing Base and Competitors
Table 110. Eisai Co. Major Business
Table 111. Eisai Co. Gastrointestinal Drugs Product and Services
Table 112. Eisai Co. Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Eisai Co. Recent Developments/Updates
Table 114. Eisai Co. Competitive Strengths & Weaknesses
Table 115. Abbvie Basic Information, Manufacturing Base and Competitors
Table 116. Abbvie Major Business
Table 117. Abbvie Gastrointestinal Drugs Product and Services
Table 118. Abbvie Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Abbvie Recent Developments/Updates
Table 120. Abbvie Competitive Strengths & Weaknesses
Table 121. Jiangzhong Basic Information, Manufacturing Base and Competitors
Table 122. Jiangzhong Major Business
Table 123. Jiangzhong Gastrointestinal Drugs Product and Services
Table 124. Jiangzhong Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Jiangzhong Recent Developments/Updates
Table 126. Jiangzhong Competitive Strengths & Weaknesses
Table 127. AOSAIKANG Pharma Basic Information, Manufacturing Base and Competitors
Table 128. AOSAIKANG Pharma Major Business
Table 129. AOSAIKANG Pharma Gastrointestinal Drugs Product and Services
Table 130. AOSAIKANG Pharma Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. AOSAIKANG Pharma Recent Developments/Updates
Table 132. AOSAIKANG Pharma Competitive Strengths & Weaknesses
Table 133. Luoxin Pharma Basic Information, Manufacturing Base and Competitors
Table 134. Luoxin Pharma Major Business
Table 135. Luoxin Pharma Gastrointestinal Drugs Product and Services
Table 136. Luoxin Pharma Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Luoxin Pharma Recent Developments/Updates
Table 138. Luoxin Pharma Competitive Strengths & Weaknesses
Table 139. LIVZON Basic Information, Manufacturing Base and Competitors
Table 140. LIVZON Major Business
Table 141. LIVZON Gastrointestinal Drugs Product and Services
Table 142. LIVZON Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. LIVZON Recent Developments/Updates
Table 144. LIVZON Competitive Strengths & Weaknesses
Table 145. Eastchina Pharma Basic Information, Manufacturing Base and Competitors
Table 146. Eastchina Pharma Major Business
Table 147. Eastchina Pharma Gastrointestinal Drugs Product and Services
Table 148. Eastchina Pharma Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Eastchina Pharma Recent Developments/Updates
Table 150. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 151. Bausch Health Major Business
Table 152. Bausch Health Gastrointestinal Drugs Product and Services
Table 153. Bausch Health Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 154. Global Key Players of Gastrointestinal Drugs Upstream (Raw Materials)
Table 155. Gastrointestinal Drugs Typical Customers
Table 156. Gastrointestinal Drugs Typical Distributors
List of Figure
Figure 1. Gastrointestinal Drugs Picture
Figure 2. World Gastrointestinal Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Gastrointestinal Drugs Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Gastrointestinal Drugs Production (2019-2030) & (M Units)
Figure 5. World Gastrointestinal Drugs Average Price (2019-2030) & (US$/Unit)
Figure 6. World Gastrointestinal Drugs Production Value Market Share by Region (2019-2030)
Figure 7. World Gastrointestinal Drugs Production Market Share by Region (2019-2030)
Figure 8. North America Gastrointestinal Drugs Production (2019-2030) & (M Units)
Figure 9. Europe Gastrointestinal Drugs Production (2019-2030) & (M Units)
Figure 10. China Gastrointestinal Drugs Production (2019-2030) & (M Units)
Figure 11. Japan Gastrointestinal Drugs Production (2019-2030) & (M Units)
Figure 12. Gastrointestinal Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Gastrointestinal Drugs Consumption (2019-2030) & (M Units)
Figure 15. World Gastrointestinal Drugs Consumption Market Share by Region (2019-2030)
Figure 16. United States Gastrointestinal Drugs Consumption (2019-2030) & (M Units)
Figure 17. China Gastrointestinal Drugs Consumption (2019-2030) & (M Units)
Figure 18. Europe Gastrointestinal Drugs Consumption (2019-2030) & (M Units)
Figure 19. Japan Gastrointestinal Drugs Consumption (2019-2030) & (M Units)
Figure 20. South Korea Gastrointestinal Drugs Consumption (2019-2030) & (M Units)
Figure 21. ASEAN Gastrointestinal Drugs Consumption (2019-2030) & (M Units)
Figure 22. India Gastrointestinal Drugs Consumption (2019-2030) & (M Units)
Figure 23. Producer Shipments of Gastrointestinal Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Gastrointestinal Drugs Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Gastrointestinal Drugs Markets in 2023
Figure 26. United States VS China: Gastrointestinal Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Gastrointestinal Drugs Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Gastrointestinal Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Gastrointestinal Drugs Production Market Share 2023
Figure 30. China Based Manufacturers Gastrointestinal Drugs Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Gastrointestinal Drugs Production Market Share 2023
Figure 32. World Gastrointestinal Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Gastrointestinal Drugs Production Value Market Share by Type in 2023
Figure 34. Prescription
Figure 35. OTC
Figure 36. World Gastrointestinal Drugs Production Market Share by Type (2019-2030)
Figure 37. World Gastrointestinal Drugs Production Value Market Share by Type (2019-2030)
Figure 38. World Gastrointestinal Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Gastrointestinal Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Gastrointestinal Drugs Production Value Market Share by Application in 2023
Figure 41. Inflammatory Bowel Disease
Figure 42. IBS Disease
Figure 43. Peptic Ulcer
Figure 44. GERD
Figure 45. Other
Figure 46. World Gastrointestinal Drugs Production Market Share by Application (2019-2030)
Figure 47. World Gastrointestinal Drugs Production Value Market Share by Application (2019-2030)
Figure 48. World Gastrointestinal Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 49. Gastrointestinal Drugs Industry Chain
Figure 50. Gastrointestinal Drugs Procurement Model
Figure 51. Gastrointestinal Drugs Sales Model
Figure 52. Gastrointestinal Drugs Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Takeda
AstraZeneca
Bayer
Pfizer
Sun Pharma
Teva
Zeria
Perrigo
Eisai Co.
Abbvie
Jiangzhong
AOSAIKANG Pharma
Luoxin Pharma
LIVZON
Eastchina Pharma
Bausch Health
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Gastrointestinal Drugs Supply, Demand and Key Producers, 2024-2030

Global Gastrointestinal Drugs Supply, Demand and Key Producers, 2024-2030

Page: 138

Published Date: 01 Apr 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Gastrointestinal Drugs market size is expected to reach $ 56930 million by 2030, rising at a market growth of 4.4% CAGR during the forecast period (2024-2030).

The key players of Gastrointestinal Drugs include Takeda, AstraZeneca and Bayer, etc. The top three players hold a share over 9%. Asia-Pacific is the largest market, has a share about 25%. In terms of product type, Prescription is the largest segment, occupied for a share of about 64%, and in terms of application, Inflammatory Bowel Disease has a share about 44 percent.

Gastrointestinal (GI) disorder is a functional disorder or disease which occurs when the main abnormality is the way the body works. In the doctor’s office, no structural or biochemical cause is seen. Gastrointestinal problems occur when nerves or muscles in any portion of the digestive tract do not function in a coordinated fashion, or when the sensitivity of the nerves of the intestines or the way in which the brain controls some of these functions is impaired. In this report, we study the drugs for gastrointestinal.

This report studies the global Gastrointestinal Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Gastrointestinal Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gastrointestinal Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Gastrointestinal Drugs total production and demand, 2019-2030, (M Units)
Global Gastrointestinal Drugs total production value, 2019-2030, (USD Million)
Global Gastrointestinal Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (M Units)
Global Gastrointestinal Drugs consumption by region & country, CAGR, 2019-2030 & (M Units)
U.S. VS China: Gastrointestinal Drugs domestic production, consumption, key domestic manufacturers and share
Global Gastrointestinal Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (M Units)
Global Gastrointestinal Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (M Units)
Global Gastrointestinal Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (M Units).

This reports profiles key players in the global Gastrointestinal Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, AstraZeneca, Bayer, Pfizer, Sun Pharma, Teva, Zeria, Perrigo and Eisai Co., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gastrointestinal Drugs market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Gastrointestinal Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Gastrointestinal Drugs Market, Segmentation by Type
Prescription
OTC

Global Gastrointestinal Drugs Market, Segmentation by Application
Inflammatory Bowel Disease
IBS Disease
Peptic Ulcer
GERD
Other

Companies Profiled:
Takeda
AstraZeneca
Bayer
Pfizer
Sun Pharma
Teva
Zeria
Perrigo
Eisai Co.
Abbvie
Jiangzhong
AOSAIKANG Pharma
Luoxin Pharma
LIVZON
Eastchina Pharma
Bausch Health

Key Questions Answered
1. How big is the global Gastrointestinal Drugs market?
2. What is the demand of the global Gastrointestinal Drugs market?
3. What is the year over year growth of the global Gastrointestinal Drugs market?
4. What is the production and production value of the global Gastrointestinal Drugs market?
5. Who are the key producers in the global Gastrointestinal Drugs market?
btl

Table of Contents

1 Supply Summary
1.1 Gastrointestinal Drugs Introduction
1.2 World Gastrointestinal Drugs Supply & Forecast
1.2.1 World Gastrointestinal Drugs Production Value (2019 & 2023 & 2030)
1.2.2 World Gastrointestinal Drugs Production (2019-2030)
1.2.3 World Gastrointestinal Drugs Pricing Trends (2019-2030)
1.3 World Gastrointestinal Drugs Production by Region (Based on Production Site)
1.3.1 World Gastrointestinal Drugs Production Value by Region (2019-2030)
1.3.2 World Gastrointestinal Drugs Production by Region (2019-2030)
1.3.3 World Gastrointestinal Drugs Average Price by Region (2019-2030)
1.3.4 North America Gastrointestinal Drugs Production (2019-2030)
1.3.5 Europe Gastrointestinal Drugs Production (2019-2030)
1.3.6 China Gastrointestinal Drugs Production (2019-2030)
1.3.7 Japan Gastrointestinal Drugs Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gastrointestinal Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gastrointestinal Drugs Major Market Trends

2 Demand Summary
2.1 World Gastrointestinal Drugs Demand (2019-2030)
2.2 World Gastrointestinal Drugs Consumption by Region
2.2.1 World Gastrointestinal Drugs Consumption by Region (2019-2024)
2.2.2 World Gastrointestinal Drugs Consumption Forecast by Region (2025-2030)
2.3 United States Gastrointestinal Drugs Consumption (2019-2030)
2.4 China Gastrointestinal Drugs Consumption (2019-2030)
2.5 Europe Gastrointestinal Drugs Consumption (2019-2030)
2.6 Japan Gastrointestinal Drugs Consumption (2019-2030)
2.7 South Korea Gastrointestinal Drugs Consumption (2019-2030)
2.8 ASEAN Gastrointestinal Drugs Consumption (2019-2030)
2.9 India Gastrointestinal Drugs Consumption (2019-2030)

3 World Gastrointestinal Drugs Manufacturers Competitive Analysis
3.1 World Gastrointestinal Drugs Production Value by Manufacturer (2019-2024)
3.2 World Gastrointestinal Drugs Production by Manufacturer (2019-2024)
3.3 World Gastrointestinal Drugs Average Price by Manufacturer (2019-2024)
3.4 Gastrointestinal Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Gastrointestinal Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Gastrointestinal Drugs in 2023
3.5.3 Global Concentration Ratios (CR8) for Gastrointestinal Drugs in 2023
3.6 Gastrointestinal Drugs Market: Overall Company Footprint Analysis
3.6.1 Gastrointestinal Drugs Market: Region Footprint
3.6.2 Gastrointestinal Drugs Market: Company Product Type Footprint
3.6.3 Gastrointestinal Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Gastrointestinal Drugs Production Value Comparison
4.1.1 United States VS China: Gastrointestinal Drugs Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Gastrointestinal Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Gastrointestinal Drugs Production Comparison
4.2.1 United States VS China: Gastrointestinal Drugs Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Gastrointestinal Drugs Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Gastrointestinal Drugs Consumption Comparison
4.3.1 United States VS China: Gastrointestinal Drugs Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Gastrointestinal Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Gastrointestinal Drugs Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Gastrointestinal Drugs Production Value (2019-2024)
4.4.3 United States Based Manufacturers Gastrointestinal Drugs Production (2019-2024)
4.5 China Based Gastrointestinal Drugs Manufacturers and Market Share
4.5.1 China Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Gastrointestinal Drugs Production Value (2019-2024)
4.5.3 China Based Manufacturers Gastrointestinal Drugs Production (2019-2024)
4.6 Rest of World Based Gastrointestinal Drugs Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Gastrointestinal Drugs Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Gastrointestinal Drugs Production (2019-2024)

5 Market Analysis by Type
5.1 World Gastrointestinal Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Prescription
5.2.2 OTC
5.3 Market Segment by Type
5.3.1 World Gastrointestinal Drugs Production by Type (2019-2030)
5.3.2 World Gastrointestinal Drugs Production Value by Type (2019-2030)
5.3.3 World Gastrointestinal Drugs Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Gastrointestinal Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Inflammatory Bowel Disease
6.2.2 IBS Disease
6.2.3 Peptic Ulcer
6.2.4 GERD
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Gastrointestinal Drugs Production by Application (2019-2030)
6.3.2 World Gastrointestinal Drugs Production Value by Application (2019-2030)
6.3.3 World Gastrointestinal Drugs Average Price by Application (2019-2030)

7 Company Profiles
7.1 Takeda
7.1.1 Takeda Details
7.1.2 Takeda Major Business
7.1.3 Takeda Gastrointestinal Drugs Product and Services
7.1.4 Takeda Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Takeda Recent Developments/Updates
7.1.6 Takeda Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Gastrointestinal Drugs Product and Services
7.2.4 AstraZeneca Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Bayer
7.3.1 Bayer Details
7.3.2 Bayer Major Business
7.3.3 Bayer Gastrointestinal Drugs Product and Services
7.3.4 Bayer Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Bayer Recent Developments/Updates
7.3.6 Bayer Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Gastrointestinal Drugs Product and Services
7.4.4 Pfizer Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Sun Pharma
7.5.1 Sun Pharma Details
7.5.2 Sun Pharma Major Business
7.5.3 Sun Pharma Gastrointestinal Drugs Product and Services
7.5.4 Sun Pharma Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Sun Pharma Recent Developments/Updates
7.5.6 Sun Pharma Competitive Strengths & Weaknesses
7.6 Teva
7.6.1 Teva Details
7.6.2 Teva Major Business
7.6.3 Teva Gastrointestinal Drugs Product and Services
7.6.4 Teva Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Teva Recent Developments/Updates
7.6.6 Teva Competitive Strengths & Weaknesses
7.7 Zeria
7.7.1 Zeria Details
7.7.2 Zeria Major Business
7.7.3 Zeria Gastrointestinal Drugs Product and Services
7.7.4 Zeria Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Zeria Recent Developments/Updates
7.7.6 Zeria Competitive Strengths & Weaknesses
7.8 Perrigo
7.8.1 Perrigo Details
7.8.2 Perrigo Major Business
7.8.3 Perrigo Gastrointestinal Drugs Product and Services
7.8.4 Perrigo Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Perrigo Recent Developments/Updates
7.8.6 Perrigo Competitive Strengths & Weaknesses
7.9 Eisai Co.
7.9.1 Eisai Co. Details
7.9.2 Eisai Co. Major Business
7.9.3 Eisai Co. Gastrointestinal Drugs Product and Services
7.9.4 Eisai Co. Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Eisai Co. Recent Developments/Updates
7.9.6 Eisai Co. Competitive Strengths & Weaknesses
7.10 Abbvie
7.10.1 Abbvie Details
7.10.2 Abbvie Major Business
7.10.3 Abbvie Gastrointestinal Drugs Product and Services
7.10.4 Abbvie Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Abbvie Recent Developments/Updates
7.10.6 Abbvie Competitive Strengths & Weaknesses
7.11 Jiangzhong
7.11.1 Jiangzhong Details
7.11.2 Jiangzhong Major Business
7.11.3 Jiangzhong Gastrointestinal Drugs Product and Services
7.11.4 Jiangzhong Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Jiangzhong Recent Developments/Updates
7.11.6 Jiangzhong Competitive Strengths & Weaknesses
7.12 AOSAIKANG Pharma
7.12.1 AOSAIKANG Pharma Details
7.12.2 AOSAIKANG Pharma Major Business
7.12.3 AOSAIKANG Pharma Gastrointestinal Drugs Product and Services
7.12.4 AOSAIKANG Pharma Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 AOSAIKANG Pharma Recent Developments/Updates
7.12.6 AOSAIKANG Pharma Competitive Strengths & Weaknesses
7.13 Luoxin Pharma
7.13.1 Luoxin Pharma Details
7.13.2 Luoxin Pharma Major Business
7.13.3 Luoxin Pharma Gastrointestinal Drugs Product and Services
7.13.4 Luoxin Pharma Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Luoxin Pharma Recent Developments/Updates
7.13.6 Luoxin Pharma Competitive Strengths & Weaknesses
7.14 LIVZON
7.14.1 LIVZON Details
7.14.2 LIVZON Major Business
7.14.3 LIVZON Gastrointestinal Drugs Product and Services
7.14.4 LIVZON Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 LIVZON Recent Developments/Updates
7.14.6 LIVZON Competitive Strengths & Weaknesses
7.15 Eastchina Pharma
7.15.1 Eastchina Pharma Details
7.15.2 Eastchina Pharma Major Business
7.15.3 Eastchina Pharma Gastrointestinal Drugs Product and Services
7.15.4 Eastchina Pharma Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Eastchina Pharma Recent Developments/Updates
7.15.6 Eastchina Pharma Competitive Strengths & Weaknesses
7.16 Bausch Health
7.16.1 Bausch Health Details
7.16.2 Bausch Health Major Business
7.16.3 Bausch Health Gastrointestinal Drugs Product and Services
7.16.4 Bausch Health Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Bausch Health Recent Developments/Updates
7.16.6 Bausch Health Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Gastrointestinal Drugs Industry Chain
8.2 Gastrointestinal Drugs Upstream Analysis
8.2.1 Gastrointestinal Drugs Core Raw Materials
8.2.2 Main Manufacturers of Gastrointestinal Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Gastrointestinal Drugs Production Mode
8.6 Gastrointestinal Drugs Procurement Model
8.7 Gastrointestinal Drugs Industry Sales Model and Sales Channels
8.7.1 Gastrointestinal Drugs Sales Model
8.7.2 Gastrointestinal Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Gastrointestinal Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Gastrointestinal Drugs Production Value by Region (2019-2024) & (USD Million)
Table 3. World Gastrointestinal Drugs Production Value by Region (2025-2030) & (USD Million)
Table 4. World Gastrointestinal Drugs Production Value Market Share by Region (2019-2024)
Table 5. World Gastrointestinal Drugs Production Value Market Share by Region (2025-2030)
Table 6. World Gastrointestinal Drugs Production by Region (2019-2024) & (M Units)
Table 7. World Gastrointestinal Drugs Production by Region (2025-2030) & (M Units)
Table 8. World Gastrointestinal Drugs Production Market Share by Region (2019-2024)
Table 9. World Gastrointestinal Drugs Production Market Share by Region (2025-2030)
Table 10. World Gastrointestinal Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Gastrointestinal Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Gastrointestinal Drugs Major Market Trends
Table 13. World Gastrointestinal Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (M Units)
Table 14. World Gastrointestinal Drugs Consumption by Region (2019-2024) & (M Units)
Table 15. World Gastrointestinal Drugs Consumption Forecast by Region (2025-2030) & (M Units)
Table 16. World Gastrointestinal Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Gastrointestinal Drugs Producers in 2023
Table 18. World Gastrointestinal Drugs Production by Manufacturer (2019-2024) & (M Units)
Table 19. Production Market Share of Key Gastrointestinal Drugs Producers in 2023
Table 20. World Gastrointestinal Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Gastrointestinal Drugs Company Evaluation Quadrant
Table 22. World Gastrointestinal Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Gastrointestinal Drugs Production Site of Key Manufacturer
Table 24. Gastrointestinal Drugs Market: Company Product Type Footprint
Table 25. Gastrointestinal Drugs Market: Company Product Application Footprint
Table 26. Gastrointestinal Drugs Competitive Factors
Table 27. Gastrointestinal Drugs New Entrant and Capacity Expansion Plans
Table 28. Gastrointestinal Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Gastrointestinal Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Gastrointestinal Drugs Production Comparison, (2019 & 2023 & 2030) & (M Units)
Table 31. United States VS China Gastrointestinal Drugs Consumption Comparison, (2019 & 2023 & 2030) & (M Units)
Table 32. United States Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Gastrointestinal Drugs Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Gastrointestinal Drugs Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Gastrointestinal Drugs Production (2019-2024) & (M Units)
Table 36. United States Based Manufacturers Gastrointestinal Drugs Production Market Share (2019-2024)
Table 37. China Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Gastrointestinal Drugs Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Gastrointestinal Drugs Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Gastrointestinal Drugs Production (2019-2024) & (M Units)
Table 41. China Based Manufacturers Gastrointestinal Drugs Production Market Share (2019-2024)
Table 42. Rest of World Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Gastrointestinal Drugs Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Gastrointestinal Drugs Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Gastrointestinal Drugs Production (2019-2024) & (M Units)
Table 46. Rest of World Based Manufacturers Gastrointestinal Drugs Production Market Share (2019-2024)
Table 47. World Gastrointestinal Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Gastrointestinal Drugs Production by Type (2019-2024) & (M Units)
Table 49. World Gastrointestinal Drugs Production by Type (2025-2030) & (M Units)
Table 50. World Gastrointestinal Drugs Production Value by Type (2019-2024) & (USD Million)
Table 51. World Gastrointestinal Drugs Production Value by Type (2025-2030) & (USD Million)
Table 52. World Gastrointestinal Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Gastrointestinal Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Gastrointestinal Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Gastrointestinal Drugs Production by Application (2019-2024) & (M Units)
Table 56. World Gastrointestinal Drugs Production by Application (2025-2030) & (M Units)
Table 57. World Gastrointestinal Drugs Production Value by Application (2019-2024) & (USD Million)
Table 58. World Gastrointestinal Drugs Production Value by Application (2025-2030) & (USD Million)
Table 59. World Gastrointestinal Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Gastrointestinal Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Takeda Basic Information, Manufacturing Base and Competitors
Table 62. Takeda Major Business
Table 63. Takeda Gastrointestinal Drugs Product and Services
Table 64. Takeda Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Takeda Recent Developments/Updates
Table 66. Takeda Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Gastrointestinal Drugs Product and Services
Table 70. AstraZeneca Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Bayer Basic Information, Manufacturing Base and Competitors
Table 74. Bayer Major Business
Table 75. Bayer Gastrointestinal Drugs Product and Services
Table 76. Bayer Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Bayer Recent Developments/Updates
Table 78. Bayer Competitive Strengths & Weaknesses
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer Gastrointestinal Drugs Product and Services
Table 82. Pfizer Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Pfizer Recent Developments/Updates
Table 84. Pfizer Competitive Strengths & Weaknesses
Table 85. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Sun Pharma Major Business
Table 87. Sun Pharma Gastrointestinal Drugs Product and Services
Table 88. Sun Pharma Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Sun Pharma Recent Developments/Updates
Table 90. Sun Pharma Competitive Strengths & Weaknesses
Table 91. Teva Basic Information, Manufacturing Base and Competitors
Table 92. Teva Major Business
Table 93. Teva Gastrointestinal Drugs Product and Services
Table 94. Teva Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Teva Recent Developments/Updates
Table 96. Teva Competitive Strengths & Weaknesses
Table 97. Zeria Basic Information, Manufacturing Base and Competitors
Table 98. Zeria Major Business
Table 99. Zeria Gastrointestinal Drugs Product and Services
Table 100. Zeria Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Zeria Recent Developments/Updates
Table 102. Zeria Competitive Strengths & Weaknesses
Table 103. Perrigo Basic Information, Manufacturing Base and Competitors
Table 104. Perrigo Major Business
Table 105. Perrigo Gastrointestinal Drugs Product and Services
Table 106. Perrigo Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Perrigo Recent Developments/Updates
Table 108. Perrigo Competitive Strengths & Weaknesses
Table 109. Eisai Co. Basic Information, Manufacturing Base and Competitors
Table 110. Eisai Co. Major Business
Table 111. Eisai Co. Gastrointestinal Drugs Product and Services
Table 112. Eisai Co. Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Eisai Co. Recent Developments/Updates
Table 114. Eisai Co. Competitive Strengths & Weaknesses
Table 115. Abbvie Basic Information, Manufacturing Base and Competitors
Table 116. Abbvie Major Business
Table 117. Abbvie Gastrointestinal Drugs Product and Services
Table 118. Abbvie Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Abbvie Recent Developments/Updates
Table 120. Abbvie Competitive Strengths & Weaknesses
Table 121. Jiangzhong Basic Information, Manufacturing Base and Competitors
Table 122. Jiangzhong Major Business
Table 123. Jiangzhong Gastrointestinal Drugs Product and Services
Table 124. Jiangzhong Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Jiangzhong Recent Developments/Updates
Table 126. Jiangzhong Competitive Strengths & Weaknesses
Table 127. AOSAIKANG Pharma Basic Information, Manufacturing Base and Competitors
Table 128. AOSAIKANG Pharma Major Business
Table 129. AOSAIKANG Pharma Gastrointestinal Drugs Product and Services
Table 130. AOSAIKANG Pharma Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. AOSAIKANG Pharma Recent Developments/Updates
Table 132. AOSAIKANG Pharma Competitive Strengths & Weaknesses
Table 133. Luoxin Pharma Basic Information, Manufacturing Base and Competitors
Table 134. Luoxin Pharma Major Business
Table 135. Luoxin Pharma Gastrointestinal Drugs Product and Services
Table 136. Luoxin Pharma Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Luoxin Pharma Recent Developments/Updates
Table 138. Luoxin Pharma Competitive Strengths & Weaknesses
Table 139. LIVZON Basic Information, Manufacturing Base and Competitors
Table 140. LIVZON Major Business
Table 141. LIVZON Gastrointestinal Drugs Product and Services
Table 142. LIVZON Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. LIVZON Recent Developments/Updates
Table 144. LIVZON Competitive Strengths & Weaknesses
Table 145. Eastchina Pharma Basic Information, Manufacturing Base and Competitors
Table 146. Eastchina Pharma Major Business
Table 147. Eastchina Pharma Gastrointestinal Drugs Product and Services
Table 148. Eastchina Pharma Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Eastchina Pharma Recent Developments/Updates
Table 150. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 151. Bausch Health Major Business
Table 152. Bausch Health Gastrointestinal Drugs Product and Services
Table 153. Bausch Health Gastrointestinal Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 154. Global Key Players of Gastrointestinal Drugs Upstream (Raw Materials)
Table 155. Gastrointestinal Drugs Typical Customers
Table 156. Gastrointestinal Drugs Typical Distributors
List of Figure
Figure 1. Gastrointestinal Drugs Picture
Figure 2. World Gastrointestinal Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Gastrointestinal Drugs Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Gastrointestinal Drugs Production (2019-2030) & (M Units)
Figure 5. World Gastrointestinal Drugs Average Price (2019-2030) & (US$/Unit)
Figure 6. World Gastrointestinal Drugs Production Value Market Share by Region (2019-2030)
Figure 7. World Gastrointestinal Drugs Production Market Share by Region (2019-2030)
Figure 8. North America Gastrointestinal Drugs Production (2019-2030) & (M Units)
Figure 9. Europe Gastrointestinal Drugs Production (2019-2030) & (M Units)
Figure 10. China Gastrointestinal Drugs Production (2019-2030) & (M Units)
Figure 11. Japan Gastrointestinal Drugs Production (2019-2030) & (M Units)
Figure 12. Gastrointestinal Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Gastrointestinal Drugs Consumption (2019-2030) & (M Units)
Figure 15. World Gastrointestinal Drugs Consumption Market Share by Region (2019-2030)
Figure 16. United States Gastrointestinal Drugs Consumption (2019-2030) & (M Units)
Figure 17. China Gastrointestinal Drugs Consumption (2019-2030) & (M Units)
Figure 18. Europe Gastrointestinal Drugs Consumption (2019-2030) & (M Units)
Figure 19. Japan Gastrointestinal Drugs Consumption (2019-2030) & (M Units)
Figure 20. South Korea Gastrointestinal Drugs Consumption (2019-2030) & (M Units)
Figure 21. ASEAN Gastrointestinal Drugs Consumption (2019-2030) & (M Units)
Figure 22. India Gastrointestinal Drugs Consumption (2019-2030) & (M Units)
Figure 23. Producer Shipments of Gastrointestinal Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Gastrointestinal Drugs Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Gastrointestinal Drugs Markets in 2023
Figure 26. United States VS China: Gastrointestinal Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Gastrointestinal Drugs Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Gastrointestinal Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Gastrointestinal Drugs Production Market Share 2023
Figure 30. China Based Manufacturers Gastrointestinal Drugs Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Gastrointestinal Drugs Production Market Share 2023
Figure 32. World Gastrointestinal Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Gastrointestinal Drugs Production Value Market Share by Type in 2023
Figure 34. Prescription
Figure 35. OTC
Figure 36. World Gastrointestinal Drugs Production Market Share by Type (2019-2030)
Figure 37. World Gastrointestinal Drugs Production Value Market Share by Type (2019-2030)
Figure 38. World Gastrointestinal Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Gastrointestinal Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Gastrointestinal Drugs Production Value Market Share by Application in 2023
Figure 41. Inflammatory Bowel Disease
Figure 42. IBS Disease
Figure 43. Peptic Ulcer
Figure 44. GERD
Figure 45. Other
Figure 46. World Gastrointestinal Drugs Production Market Share by Application (2019-2030)
Figure 47. World Gastrointestinal Drugs Production Value Market Share by Application (2019-2030)
Figure 48. World Gastrointestinal Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 49. Gastrointestinal Drugs Industry Chain
Figure 50. Gastrointestinal Drugs Procurement Model
Figure 51. Gastrointestinal Drugs Sales Model
Figure 52. Gastrointestinal Drugs Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Takeda
AstraZeneca
Bayer
Pfizer
Sun Pharma
Teva
Zeria
Perrigo
Eisai Co.
Abbvie
Jiangzhong
AOSAIKANG Pharma
Luoxin Pharma
LIVZON
Eastchina Pharma
Bausch Health
jiaGou

Add To Cart

gouMai

Buy Now